Phase I trial of bortezomib (PS-341) in combination with docetaxel in patients with advanced solid tumors
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Johns Hopkins University, National Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2245388911
